Fortrea Holdings Inc. (FTRE) vs Vera Therapeutics, Inc. (VERA)

Fortrea Holdings Inc. and Vera Therapeutics, Inc. are both Biotechnology companies. Fortrea Holdings Inc. and Vera Therapeutics, Inc. are of similar size ($2.2B and $2.1B). Vera Therapeutics, Inc. has the higher net margin (0.00% vs −3.18%) and the higher return on invested capital (0.00% vs −0.48%). Across the 14 metrics below, Fortrea Holdings Inc. leads on 7 and Vera Therapeutics, Inc. on 7.

Valuation

Metric FTRE VERA Biotechnology median
P/E n/m n/m 8.50
P/S 0.80 n/m 9.71
P/B 4.07 4.91 2.13
Price to free cash flow 10.77 n/m 20.82
EV/EBITDA 44.71 n/m 0.64
EV/Sales 1.13 n/m 9.21
Earnings yield (4.05%) (21.02%) (33.15%)
Free cash flow yield 9.29% (16.92%) (25.50%)

Profitability

Metric FTRE VERA Biotechnology median
Gross margin 19.30% 0.00% 65.16%
Operating margin (0.40%) 0.00% 0.00%
Net margin (3.18%) 0.00% 0.00%
Free cash flow margin 7.40% 0.00% 0.00%
Return on equity (15.30%) (91.75%) (56.36%)
Return on assets (3.07%) (72.32%) (48.04%)
Return on invested capital (0.48%) 0.00% 0.00%

Growth

Metric FTRE VERA Biotechnology median
Revenue growth (TTM) (2.09%) — 6.02%
EPS growth (last fiscal year) (194.55%) (69.45%) 30.26%
Revenue growth, 5-year CAGR 1.09% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FTRE VERA Biotechnology median
Debt to equity 2.01 0.18 0.00
Current ratio 0.96 10.92 4.72
Net debt to EBITDA 266.13 2.00 0.96

Dividend

Metric FTRE VERA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric FTRE VERA Biotechnology median
Market cap 2.16b 2.06b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack